Atlas Trials

Atypical Burkitt/Burkitt-Like Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Atypical Burkitt/Burkitt-Like Lymphoma

RecordFirmDate
Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT02199184)M.D. Anderson Cancer Center2015-01-14

Track Atypical Burkitt/Burkitt-Like Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.